SCHEMBL30926445

SCHEMBL30926445

COc1ccc(NC(=O)c2cccc(S(=O)(=O)Nc3ccc(Br)cc3)c2)cc1

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.82
KMT2A Q03164 7/20 0.82
ADORA3 P0DMS8 1/20 0.82
SLC6A3 Q01959 1/20 0.82
LMNA P02545 3/20 0.72
HTT P42858 3/20 0.72
SMN1; SMN2 Q16637 3/20 0.72
MAPT P10636 2/20 0.72
ALOX12 P18054 1/20 0.72
F2 P00734 1/20 0.61
CTDSP1 Q9GZU7 2/20 0.60
POLB P06746 1/20 0.60
CACNA1B Q00975 1/20 0.60
APBA1 Q02410 1/20 0.60
ALDH1A1 P00352 1/20 0.60
RAB9A P51151 2/20 0.59
NR2F2 P24468 1/20 0.59
MAPK1 P28482 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180406 1.00 MEN1 (0.82) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL27180991 1.00 MEN1 (0.82) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL4247855 0.91 MEN1 (0.74) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL13532171 0.91 MEN1 (0.77) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL6269502 0.91 MEN1 (1.00) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL13532178 0.90 KMT2A (0.69) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL15705229 0.90 KMT2A (0.69) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL30926720 0.89 MEN1 (0.67) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL27181006 0.89 MEN1 (0.67) MEN1KMT2AADORA3SLC6A3LMNA
SCHEMBL13532193 0.89 MEN1 (0.74) MEN1KMT2AADORA3SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885ADORA3 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.